BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Authors » Jim Stommen

Articles by Jim Stommen

The MDD Interview: Head of Pennsylvania Bio hails growth in the life sciences sector

Nov. 21, 2012
By Jim Stommen
Christopher Molineaux is president of Pennsylvania Bio, the only statewide trade association for the life sciences industry whose membership includes medical device, diagnostic, biotechnology, pharmaceutical and research organizations. Prior to joining Pennsylvania Bio in September 2009, he served as worldwide VP of pharmaceutical communication and public affairs for Johnson & Johnson.
Read More

The MDD Interview: Chronic disease management cited as key market for VitalSims

Nov. 15, 2012
By Jim Stommen
Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes.
Read More

The MDD Interview: Serious gaming seen as a key in training healthcare professionals

Nov. 8, 2012
By Jim Stommen
Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes. Chris has more than 25 years in start-up and business management experience including serving as CEO of QuickStep Games, a developer of active play video games; managing partner of Ice Studios, a new media video production house; and former president of Dexxon Capital Corp., a business finance company.
Read More

The MDD Interview: Emerick cites culture of 'teamwork, humility' as key drivers for his firm

Nov. 1, 2012
By Jim Stommen

The MDD Interview: Company rises from garage roots to thrive as a medical supplier

Oct. 25, 2012
By Jim Stommen

The MDD Interview: Allen on hospital safety: 'You have to engage everyone in process'

Oct. 18, 2012
By Jim Stommen
Steve Allen, MD, has been CEO of Nationwide Children's Hospital in Columbus, Ohio, since July 2006. Allen is credited to driving the hospital's national prominence resulting in recognition as one of the best children's hospitals by both U.S. News and World Report and Parent magazine. Prior to coming to Columbus, Steve was a physician, scientist, teacher and executive in the Texas Medical Center in Houston for 24 years. He is board-certified in anesthesiology and critical care medicine.
Read More

The MDD Interview: Ohio-born hospital safety effort spreading the message nationally

Oct. 11, 2012
By Jim Stommen
Steve Allen, MD, has been CEO of Nationwide Children's Hospital in Columbus, Ohio, since July 2006. Allen is credited to driving the hospital's national prominence resulting in recognition as one of the best children's hospitals by both U.S. News and World Report and Parent magazine. Prior to coming to Columbus, Steve was a physician, scientist, teacher and executive in the Texas Medical Center in Houston for 24 years. He is board-certified in anesthesiology and critical care medicine.
Read More

The MDD Interview: Broadened role ahead for Indiana Health Information Exchange

Oct. 4, 2012
By Jim Stommen

The MDD Interview: Apple: 'Community effort' led to what is now the nation's largest HIE

Sep. 27, 2012
By Jim Stommen
Harold Apple is CEO and president of the Indiana Health Information Exchange, the nation's largest HIE organization. IHIE connects the state's hospitals, physicians, long-term care facilities and other healthcare providers, enabling medical information to follow patients regardless of treatment location to improve care coordination and patient outcomes. Physicians in the IHIE network provide care to more than 10 million patients.
Read More

The MDD Interview: Springboard Enterprises helps women entrepreneurs get funding

Sep. 13, 2012
By Jim Stommen
Kay Koplovitz is chairman and co-founder of Springboard Enterprises, a platform where entrepreneurs, investors and industry experts meet to build women-led businesses. Springboard educates, sources, coaches, showcases and supports high-growth companies seeking equity capital for expansion. She also is chairman/CEO of Koplovitz & Co. Koplovitz was the founder of cable TV networks USA Network, the Sci-Fi Channel and USA Networks International. She talked with MDD Contributing Writer Jim Stommen about Springboard's push for women entrepreneurs.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing